McDavid Stilwell
Net worth: 145 339 $ as of 2024-04-29
Career history of McDavid Stilwell
Former positions of McDavid Stilwell
| Companies | Position | Start | End |
|---|---|---|---|
| COHERUS BIOSCIENCES, INC. | Director of Finance/CFO | 2021-03-07 | 2023-12-07 |
| Investor Relations Contact | 2020-09-30 | 2021-03-07 | |
| Public Communications Contact | 2020-09-30 | 2021-03-07 | |
| OREXIGEN THERAPEUTICS, INC. | Investor Relations Contact | 2012-02-29 | 2016-10-31 |
| Public Communications Contact | 2012-02-29 | 2016-10-31 | |
GTx, Inc.
 GTx, Inc. Pharmaceuticals: MajorHealth Technology GTx, Inc. is a a biopharmaceutical company, which engages in the discovery, development, and commercialization of small molecules for the treatment of muscle-related diseases and other serious medical conditions. It focuses on developing selective androgen receptor modulators and selective androgen receptor degrader for the treatment of breast cancer, stress urinary incontinence, Duchenne muscular dystrophy, and prostate cancer. The company was founded by Marc Steven Hanover and Mitchell Shuster Steiner on September 24, 1997 and is headquartered in Memphis, TN. | Public Communications Contact | 2004-12-31 | 2011-12-31 |
| SANGAMO THERAPEUTICS, INC. | Investor Relations Contact | 2016-10-31 | - |
| Public Communications Contact | 2016-10-31 | - |
Training of McDavid Stilwell
| St. John's College | Undergraduate Degree |
| Harvard Business School | Masters Business Admin |
Statistics
International
| United States | 7 |
Operational
| Public Communications Contact | 4 |
| Investor Relations Contact | 3 |
| Undergraduate Degree | 1 |
Sectoral
| Health Technology | 5 |
| Consumer Services | 3 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 2 |
|---|---|
| SANGAMO THERAPEUTICS, INC. | Health Technology |
| COHERUS BIOSCIENCES, INC. | Health Technology |
| Private companies | 2 |
|---|---|
Orexigen Therapeutics, Inc.
 Orexigen Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Orexigen Therapeutics, Inc. is a biopharmaceutical company, which focuses on the development of pharmaceutical product candidates for the treatment of obesity. Its primary activities include recruiting personnel, conducting research and development, including clinical trials, raising capital, and preparing for the marketing and commercialization of its product, contrave. The company was founded by Eckard Weber in September 2002 and is headquartered in La Jolla, CA. | Health Technology |
GTx, Inc.
GTx, Inc. Pharmaceuticals: MajorHealth Technology GTx, Inc. is a a biopharmaceutical company, which engages in the discovery, development, and commercialization of small molecules for the treatment of muscle-related diseases and other serious medical conditions. It focuses on developing selective androgen receptor modulators and selective androgen receptor degrader for the treatment of breast cancer, stress urinary incontinence, Duchenne muscular dystrophy, and prostate cancer. The company was founded by Marc Steven Hanover and Mitchell Shuster Steiner on September 24, 1997 and is headquartered in Memphis, TN. | Health Technology |
- Stock Market
- Insiders
- McDavid Stilwell
- Experience
